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Abstract.  E-selectin elicits cell adhesion by binding to 
the cell surface carbohydrate,  sialyl Lewis X  (sLex). 
We evaluated the effects of mutations in the E-selectin 
lectin domain on the binding of a panel of anti- 
E-selectin mAbs and on the recognition of immobi- 
lized sLe  x glycolipid. Functional residues were then 
superimposed onto a three-dimensional  model of the 
E-selectin lectin domain.  This analysis demonstrated 
that the epitopes recognized by blocking mAbs map to 
a patch near the antiparallel  beta sheet derived from 
the NH2 and COOH termini of the lectin domain and 
two adjacent loops. Mutations that affect sLe  ~ binding 
map to this same region.  These results thus define a 
small region of the E-selectin lectin domain that is 
critical for carbohydrate recognition. 
T 
HE selectins are three cell adhesion molecules that are 
unified  structurally  by the inclusion  of lectin,  EGF- 
like and complement binding-like domains (4, 26, 34, 
51, 54) and functionally by their ability to mediate cell bind- 
ing through  interactions  between their lectin  domains and 
cell surface carbohydrate ligands (8, 53). L-selectin is found 
on leukocytes and is involved with the trafficking of lympho- 
cytes to peripheral  lymphoid tissues (20)  and  with acute 
neutrophil-mediated  inflammatory  responses (62). It appears 
to recognize an unknown sialylated,  fucosylated, sulfated 
carbohydrate ligand(s) on at least two endothelial  glycopro- 
teins (24, 57), one of which has recently been cloned (35). 
E-selectin is an endothelial  adhesion  molecule that is in- 
duced by various inflammatory stimuli  (3, 28, 40) and that 
recognizes  the neutrophil  and monocyte cell surface carbo- 
hydrate, sialyl Lewis x (sLex)  ~  (39, 43, 56, 60). In addition, 
E-selectin may also be involved with the recognition  of an 
sLex-like carbohydrate on the surface of a skin-homing  sub- 
set  of lymphocytes (44,  50).  The  minimum-sized  sLe  ~- 
related carbohydrate recognized by E-selectin is a tetrasac- 
charide of the structure Sialic Acid c~2-3 Galactose/31-4 
(Fucose t~l-3)  N-Acetyl  Gluclosamine  (58).  P-selectin  is 
found in alpha granules of platelets and Weible-Palade bod- 
ies of endothelial  cells (5, 41). Its surface expression  is in- 
duced within minutes of exposure to thrombin, substance P, 
histamine,  or peroxide,  and it appears to recognize a carbo- 
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hydrate that is either identical  to or closely related  to sLe  x 
on both neutrophil  and monocyte cell surfaces (31, 32, 42, 
46). In the case of all three selectins,  the adhesive  interac- 
tions  require t~2-3-1inked sialic  acid,  while in the case of 
E-selectin,  and probably P-selectin,  the recognition  event 
also requires a fucose residue (8, 53, 58). The adhesive inter- 
actions between selectins and their carbohydrate ligands may 
be relatively weak, since L-selectin and P-selectin have been 
shown to be involved in the relatively  low affinity "rolling" 
of leukocytes along the endothelium during inflammatory re- 
sponses (9, 36, 38, 59). 
The molecular details of  the interactions  between selectins 
and their carbohydrate ligands are poorly understood. The 
fact  that  selectins  require  sialic  acid for adhesion,  when 
coupled with the finding that certain negatively charged car- 
bohydrate  polymers (fucoidin,  dextran  sulfate,  and  poly- 
phosphomannan  ester) are effective inhibitors of some selec- 
tin-mediated cell adhesion, is consistent with the involvement 
of positively charged amino acids in carbohydrate recogni- 
tion (24, 42, 46, 57, 58, 69). However, such protein-sialic 
acid interactions  can be accomplished by noncharged  side 
chains. Crystallographic  analysis of the low-affinity interac- 
tion between the influenza hernagglutinin glycoprotein, which 
is not related to type C lectins, and its ligand, sialic acid, re- 
vealed that this interaction  involves diverse amino acid side 
chains,  none  of which are positively charged  (66).  That 
a simple face or pocket of E-selectin, and potentially P-selec- 
tin  (46),  is involved with recognition  of sLe  x is suggested 
by nuclear magnetic resonance (NMR) solution analyses of 
sLe  x structure.  This analysis  demonstrated that the critical 
sialic acid and fucose residues both point to one face of this 
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inactive form of this carbohydrate (with 2-6 linked  sialic 
acid) has these two components pointing in different direc- 
tions (1, 58). A similar structural analysis of another ligand 
for E-selectin, sialyl Lewis a (sLea: Sialic Acid a2-3 Galac- 
tose ~1-3  (Fucose otl-4) N-Acetyl Glucosamine),  has  re- 
vealed that the critical sialic acid and fucose residues again 
point to one face of the tetrasaccharide and are separated by 
approximately the same distance as in sLe  x (1, 58). These 
results are all consistent with the recognition of sLe  x by a 
relatively small region of E-selectin. 
To analyze the adhesive interactions between  sLe  X and 
E-selectin on a more detailed level, we have undertaken two 
strategies. First, chimeric human-rabbit lectin domains have 
been generated based upon amino acid sequence differences 
between the two species.  These chimeras have then been 
used to map epitopes recognized by blocking antibodies to 
human E-selectin. Second, E-selectin mutants with alanine 
substitutions have been generated and analyzed for binding 
to a panel of blocking and nonblocking antibodies and for 
their  ability  to  adhere  to  immobilized  sLe  x glycoplipid. 
Residues  affecting various aspects  of E-selectin structure 
and/or function have then been superimposed onto a three- 
dimensional model of the E-selectin lectin domain generated 
using the  structural  coordinates determined for a  related 
C-type lectin, the mannose binding protein (67). Together, 
these data point to a relatively small region of the E-selectin 
lectin domain that is critical for recognition of sLe  x. 
Materials and Methods 
Production and Characterization of 
Anti-E-selectin  mAbs 
mAbs to both human and rabbit E-selectin were generated by immunization 
of mice with COS cells transiently expressing E-selectin. COS cells (5  x 
107/0.8 ml in Dulbecco's PBS (DPBS) were transfected by electroporation 
(350 V, 250 ~E Bio-Rad Gene Pulser) with 20 t~g human or rabbit E-selec- 
tin cDNA, incubated on ice for 10 rain, resuspended in DME/10% FBS and 
plated at 107 cells per 225-cm2-tissue culture flask. Transfected cells were 
harvested nopenzymatically at 48-72 h, washed twice, and resuspended in 
DPBS. Mice were routinely immunized i.p. with 1 x  107 cells and boosted 
every 2-3 wk. Hybridomas were produced by fusion of immunized mouse 
splenocytes with SP2/0 cells using standard techniques (19).  Hybridoma 
supernatants were screened by a differential binding ELISA to Immulon 2 
microtiter plates (Dynatech Laboratories, Inc., Chantilly, VA) coated with 
detergent extracts of membranes from E-selectin transfected and control/ 
nontransfected COS cells. Crude membrane fractions were extracted in 2 % 
Triton X-100, 150 mM NaCI, 50 mM Tris, pH Z5 (2.5  x  l0  s cell equiva- 
lents/ml). Extracts were diluted in 50 mM Na2CO3, pH 9.6, and directly 
coated onto assay plates.  Anti-human antibodies were also screened by 
ELISA for  selective binding to  human  umbilical vein endothelial cells 
(HUVECs) treated for 4 h with rhIL-la (550 pg/ml) and rhTNF (400 U/ml) 
compared with untreated HUVECs. The specificity of these mAbs were 
confirmed with cytokine treated HUVECs, and transiently transfected COS 
ceils by immunoblotting, irnmunoprecipitation, and indirect immunofluo- 
rescence. 
mAbs 7H5 (IgG3),  8E4 (IgG2A), 3B'7  (IgGl),  ID6 (IgGi),  4D9 (IgG3), 
IE5  (IgGl),  9AI (IgGl),  7El0  (IgGl),  and IB3 (IgM)  were  generated  to  hu- 
man E-selectin,  while rnAbs 14G2 (IgGl), I  IG5 (IgM), and 9H9 (IgM) 
were  produced to  rabbit  E-selectin.  Ascites  was  produced by  standard  tech- 
niques  (23)  and antibodies  were purified  by the  caprylic  acid  precipitation 
method  as  described  (48).  mAbs BBA I  and BBA 2 were purchased  from 
British  Biotechnology  (Oxford,  England)  while  mAb ENA-I was  purchased 
from San Bio (Uden, Netherlands). 
Adhesion Assays 
Confluent cultures of HUVECs plated onto gelatin-coated 96-well tissue 
culture plates (Costar Corp., Cambridge, MA) were treated for 4 h with 
rhIL-1 t~ (550 pg/ml) and rhTNF (400 U/nil). Wells were washed three times 
with DPBS and incubated for 1 h at 37~  in DPBS containing 1% BSA and 
10  /~g/ml  of  designated  mAb.  HL60  cells  were  washed  twice  and 
resuspended in RPMI Medium 1640 (Gibco Laboratories, Grand Island, 
NY) at 5  x  106 cells/ml and labeled for 30 min at 37~  with 40 #g/ml 6 
Carboxyfluorescein (6-CFDA). 6-CFDA loaded HL60 cells (100,000  cells 
per well) were added and incubated for 20 rain at 25~  Wells were filled 
with RPMI and plates were sealed, inverted, and spun for 6 min at 500 g. 
Nonadherent  cells  were  removed  by  aspiration  and  plates  read  in  a 
CytoFluor 2300 fluorescent plate reader (Millipore Corp., Bedford, MA.). 
COS cells were plated at 5  ￿  105 cells per 35-mm-diam well 18 h be- 
fore transfection. Cells were washed with DPBS and 2/zg DNA was added 
in 1 ml DME containing 10%  Nutridoma (Boebringer-Mannheim Corp., 
Indianapolis, IN), 50/~M chloroquine, and 500 ng/ml DEAE dextran. After 
incubation for 2.5 h at 37~  the wells were aspirated and the cells were 
incubated in  Iscove's modified Dulbecco's medium  (IMDM)  containing 
10%  FBS and  10%  DMSO for 2.5 rain.  Wells were aspirated and cells 
grown in IMDM containing 10%  FBS at 37~  for 48-72 h. For adhesion 
assays, 5  ￿  106 6-CFDA loaded HL60 cells were added to each 35-mm- 
diam well and incubated for 30 min at 25~  Wells were washed 3 times 
with RPMI and the fluorescence associated with adherent cells determined 
in the CytoFluor 2300 plate reader. 
Indirect Immunofluorescence 
Transiently  transfected COS  cells were  fixed in  DPBS  containing  1% 
(wt/vol) formaldehyde for 15 min at 25~  After two washes with DPBS, 
the cells were blocked with DPBS containing 10% horse serum (DPBS/10% 
HS) for 30 min at room temperature. Ceils were incubated for 30 min with 
5 #g/ml mAbs 387, 8E4, 7H5, or 14G2 in DPBS/10% HS and then washed 
three  times  with  DPBS.  After  a  30-min  incubation  with  rhodamine- 
conjugated  goat  anti-mouse  IgG,  cells  were  washed  with  DPBS,  and 
fluorescence observed on a Zeiss Axioskop microscope (Carl Zeiss, Inc., 
Thornwood, NY). 
Human-Rabbit Chimeric E-selectin Constructs 
Expression of  truncated forms of human and rabbit E-selectin  on the surface 
of COS  cells was  achieved by  fusing  the  selectin sequences  with  the 
carboxy-terminal 37 amino acids of CD16 which contains the signal se- 
quence for cell surface anchorage via a glycosylphosphatidylinositol (GPI) 
linkage (49). All E-selectin fragments were generated by polymerase chain 
reaction (PCR) and cloned into the plasmid vector pBC12BI (11) that had 
been modified to contain the CDI6 sequences. Recombinant genes were ex- 
pressed using the initiating Met codon from the rat preproinsulin gene in 
pBC12BI and the primary translation product contains five amino acids de- 
rived from the insulin signal sequence. The human lectin-EGF construct 
contained amino acids -15 through +157 (4), the rabbit lectin-EGF con- 
tained residues -17 through +156 (30), while the HuRa-1 contained amino 
acids -15 to +9 of human E-selectin contiguous with residues 10 through 
156 of rabbit E-setectin. The CD16 sequences required for GPI anchorage 
to the cell surface were fused to the carboxy termini of each construct. 
Construction and Expression of  E-selectin-IgG 
Chimera Mutants 
Production and characterization of the E-selecfin-IgG chimera has been 
previously described (18).  Mutations were introduced into the lectin do- 
main of this chimera by the method of Kunkel (29) using the Muta-Gene 
Phagemid in vitro Mutagenesis Kit (BioRad Laboratories, Richmond, CA) 
according  to  the  manufacturer's  instructions.  Correct  mutants  were 
confirmed by sequencing and the mutant chimeras were transiently ex- 
pressed and secreted by transfection of 293 cells (63). The concentration 
of  each chimera in the resultant supernatants were then quantified by ELISA 
using an anti-human IgG1-Fc specific mouse mAb as previously described 
(61).  Mutation sites are defined using the following nomenclature: Kll3A 
is a mutant where the lysine (K) at position 113 is changed to an alanine (A). 
mAb Binding of  E-selectin-IgG Mutants 
Reactivity of the mutant E-selectin-IgG chimeras with the various antibod- 
ies was determined using a  previously described ELISA format (61)  in 
which the purified mAbs were coated onto microtiter wells, then blocked 
with BSA. 293 cell supernatants containing equal concentrations of wild- 
type or mutant chimeras were incubated in the wells, followed by washing 
The Journal of Cell Biology.  Volume 119,  1992  216 and detection of the captured chimeras with HRP-conjugated  goat poly- 
clonal anti-human Fc antibody. 
sLe  ￿9  Binding of  E-selectin-lgG Mutants 
Assays for binding of the mutant E-selectin-lgG chimeras to immobilized 
sLc  x glycolipids  were performed  essentially as  described (18).  Briefly, 
sLe  x glycolipids  were dried onto microtiter wells,  washed with distilled 
water,  and then blocked with BSA. Biotinylated goat anti-human IgG Fc 
and alkaline phosphatase-streptavidin (CALTAG Laboratories, South San 
Francisco, CA) were each diluted 1:1,000 into 293 cell supernatants con- 
taining equal concentrations of wild-type  or mutant chimeras and allowed 
to form a complex before addition to the wells.  These supernatants were 
then incubated on the sLe  x glycolipid-coated  surfaces,  followed by wash- 
ing, addition of substrate (p-nitrophenyl  phosphate), and measurement of 
the OD at 405 nm. 
Generation of  a Model of  the E-selectin Lectin Domain 
The model of E-selectin was generated based on the crystal structure of the 
rat mannose-binding protein (MBP) (67).  The sequence of E-selectin was 
aligned with those of mouse L-selectin (LHR) (34) and MBP using the 
alignment  of the latter two proteins provided (67). Eleven insertions and two 
deletions in E-selectin relative to MBP mapped to four surface loops in the 
MBP structure. MBP (molecule 1) was transformed into E-selectin in three 
steps.  First, all residues except those involving insertions/deletions were 
changed to the E-selectin sequence using the INSIGHT-II program (Biosym 
Technologies,  San Diego,  CA).  If possible, conformations of E-selectin 
sidechains were kept similar to those of MBP,, otherwise they were based 
on rotamer libraries (47), packing and hydrogen-bonding  considerations. 
Second, possible loop structures for the E-selectin insertions/deletions  were 
gleaned from a search of crystal structures in the Protein Data Bank (2) 
using the INSIGHT-H program. Third, each of the 30 water molecules pres- 
ent in the MBP crystal structure was evaluated regarding its retention in the 
E-selectin model. Only seven waters were included in the E-selectin model, 
four of which corresponded to MBP water molecules  23, 24, 25, and 30. 
The E-selectin model was subjected to 6000 cycles of energy minimiza- 
tion using the DISCOVER  program ~iosym Technologies).  The all-atom 
AMBER forcetield (64, 65) was used for all calculations,  using a 14]k  cutoff 
for nonbonded interactions and a linear dielectric (e =  4.0*0. Hydrogen 
atoms were added to the structure using INSIGHT-H and positions ofhydro- 
gens on Ser, Thr, and 'Pyr sidechains and on water molecules were checked 
visually for proper alignment in hydrogen bonds, if  present. Energy minimi. 
zation was performed in six stages of 1,000 cycles each. In stage 1, steepest- 
descents minimization was used with Ca atoms of residues  $2-V27, Q30- 
$40, Y49-R54,  W60-V61, N75-N82, E88-I93,  and W103-TI19 constrained 
to their initial positions using a force constant of 100 kcal//L 105 hydrogen- 
bond constraints (50 kcal/mol) were also invoked involving primarily hydro- 
gen bonds between residues in the ~3 strands and c~ helices.  This allowed 
loop structures and sidechalns to move while preserving the integrity of the 
secondary structure present in the E-selectin model. Instages 2 and 3, the 
Cot tether force constant was reduced to 50 and 10 kcal/A, respectively, and 
conjugate gradients minimization was used. In stages 4 and 5, the Cc~ con- 
straints were released and, finally, in stage 6 the hydrogen-bond constraints 
were released. The MBP crystal structure includes two Ho  2+ ions which 
occupy the two Ca~+-binding sites in MBE E-selectin retains one Ca  ~+- 
binding site, but loses the second (see Results). Since the AMBER forcefleld 
(64, 65) does not include a representation for Ca  ~+, the Ca  ~+ atom was re- 
moved  and the sidechains which coordinate the Ca  ~+ (E80,  N82,  E88, 
N105, D106) were fixed throughout the minimization procedure. 
Results 
Characterization of a Panel of  E-selectin Antibodies 
To facilitate the study of E-selectin structure and function, 
we generated a panel of blocking and nonhlocking mAbs 
directed against human and rabbit E-selectin (see Materials 
and Methods).  Three anti-human E-selectin mAbs (7H5, 
8E4, and 3B7) were found to inhibit the adhesion of HL60 
cells to cytokine activated HUVECs and E-selectin trans- 
fected COS cells (Fig. 1 A). Cross-reactivity studies demon- 
strated that these three blocking mAbs did not recognize rab- 
bit E-selectin (Fig. 1 B), a result that facilitated mapping of 
the epitopes recognized by these mAbs (see below).  The 
commercially available anti-human E-selectin mAbs, BBA1, 
BBA2,  and  ENA-1, also  did  not cross  react  with rabbit 
E-selectin. (Fig. 1 B). While none of these three commercial 
mAbs significantly blocked E-selectin-mediated HL60 ad- 
herence in our cell adhesion assay (Fig. 1 el), BBA2 has clear 
adhesion blocking activity in assays done at low temperature 
(45) and ENA-1 has been shown to block neutrophil adhesion 
to activated HUVECs (37). Furthermore, BBA2 and ENA-1 
both effectively inhibit binding of E-selectin to immobilized 
sLe  ~ glycolipid (18).  Since sLe  ~ is the major carbohydrate 
ligand for E-selectin on the leukocyte cell surface, it seemed 
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Figure L  Characterization of 
anti-E-selectin mAbs. (A) In- 
hibition of HL60 cell adhesion 
to cytokine activated HUVECs 
(i)  and  E-seleetin  transfect- 
ed  COS  cells  (~)  by  anti- 
E-selectin mAbs.  Cells  were 
~.~  preincubated  with  mAbs  (10 
/zg/ml) for 1 h at room temper- 
~_.~  ature and HL60 cell adhesion 
...........................  determined  as  described  in 
........................  Materials and Methods.  Each 
.....................  bar  represents  the  mean  of 
.......... ~  ..........  triplicate  determinations  ex- 
............. , -~-~  pressed as a percent of control 
.........................  binding. Antibody  treatments 
resulting  in  <40  percent  of 
....  control adhesion were scored 
....  as blocking  in these  assays. 
0.2  0.4  0.6  0.8  t.0  1.2  (B) Binding of anti-E-seleetin 
AI~SORBANCE (490 nm)  mAbs to human (=) and rab- 
bit (m) E-selectin. Antibodies 
(10/~g/ml) were  incubated for  1 h  at room temperature on 96-well microtiter plates to  which recombinant soluble human or rabbit 
E-selectin had been bound.  Wells were washed and incubated with HRP-coupled  goat anti-mouse IgG, washed, and developed using 
standard protocols. 
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of blocking antibodies (7H5,  8FA, 3B7, BBA2 and ENA-1)  Human 
might indicate region(s) of E-selectin involved with carbohy-  Rabbit 
drate recognition and resultant cell adhesion. In addition,  Human 
the mapping  of regions  recognized by nonblocking  mAbs  Rabbit 
should confirm the site(s) found for blocking antibodies by  Human 
indicating regions not involved with carbohydrate binding.  Rabbit 
Therefore, the initial step in analyzing the regions of  E-selec- 
tin involved in carbohydrate interactions consisted of map- 
ping the epitopes recognized by blocking and nonblocking 
mAbs. 
Analysis of E-selectin mAb Binding 
The E-selectin mutagenesis strategy was driven by two ma- 
jor  considerations.  The  first  consideration derived  from 
previous work which localized the epitope recognized by 
blocking  mAb,  Mel  14,  to  the  NH2-terminal  53  amino 
acids of L-selectin (6). Additional mapping showed that part 
of the Mel 14 epitope was found within the first eight amino 
acids (D. Erbe, unpublished data). One prediction of this re- 
sult is that blocking mAbs directed against E-selectin may 
also recognize the lectin domain NH2 terminus. A  second 
strategy targeted positively charged residues in the lectin 
domain of E-selectin. These residues could contribute sig- 
nificantly to binding due to the previously mentioned possi- 
bility that a basic side chain may form a salt bridge with the 
sialic acid carboxylate, and due to the fact that hydrogen 
bonds involving charged residues contribute more to binding 
affinity than those involving uncharged residues (7,  17). Fi- 
nally, charged amino acids are usually found on protein sur- 
faces where they play a prominent role in antigenic epitopes 
(25, 52). 
As described above,  none of the anti-human E-selectin 
blocking mAbs reacted with rabbit E-selectin. Comparison 
of the amino acid sequences of the lectin domains of human 
and rabbit E-selectin showed that 5 of 16 differences were 
clustered in the NH2-terminal nine amino acids (Fig. 2 A). 
To determine whether blocking mAbs map to this region, a 
chimeric  protein  containing  rabbit  E-selectin  lectin  and 
EGF-like domains with the NH2-terminal nine amino acids 
replaced  by  the  corresponding  sequence  from  human 
E-selectin was generated (Hu-Ra-1) (see Fig. 2 B). This con- 
struct was produced as a fusion of the lectin and EGF-like 
domains with a region of CD16 sufficient to allow anchoring 
of  the expressed protein to the cell surface by a glycosyl-ino- 
sitol phosphate linkage (Fig. 2 B). The EGF-like domain was 
included because previous data suggested that the conforma- 
tion of selectin lectin domains required an adjacent EGF-like 
domain (6, 60). Indirect immunofluorescence on COS cells 
transfected with human lectin-EGF-CD16,  rabbit lectin-EGF- 
CD16, or the human-rabbit chimera (Hu-Ra-1) demonstrated 
that human amino acids 1-9 in the rabbit E-selectin back- 
ground were sufficient to confer mAb 7H5 and 8E4 binding 
but not mAb 3B7 binding (Fig. 3 A). In similar experiments, 
ENA-1, but not BBA2, bound to HuRa-1 (not shown). In ad- 
dition, adhesion of HL60 cells to Hu-Ra-l-transfected COS 
cells was  inhibited by mAbs 7H5  and 8E4, but was unaf- 
fected by mAb 3137 or the nonblocking mAb 14G2 (Fig. 4). 
These data were consistent with the localization of the major 
antigenic determinants recognized by three blocking mAbs 
(7H5,  8E4,  and ENA-1) to the NH~-terminal  nine amino 
acids of  human E-selectin. A second human-rabbit chimeric 
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Figure 2. E-selectin constructs. (A) Amino acid alignment of the 
lectin domains of human and rabbit E-selectin beginning at the 
putative NH2 terminus of the mature polypeptide. Amino acid 
substitutions in the rabbit peptide are depicted, all other positions 
are identical with the human residues. (B) E-selectin constructs 
used to map mAbs and sLe  ~ binding sites. The human E-selectin 
contained amino acids 1-157, the rabbit E-selectin encoded amino 
acids 1-156 and HuRa-1 contained residues 1-9 of human contigu- 
ous with residues 10-156 of rabbit E-seleetin. Each is anchored to 
the cell surface via a GPI link encoded by CD16 sequences. Also 
shown  is an E-selecdn-IgG chimera (E Sel-IgG)  containing the lee- 
tin, EGF-like and complement binding-like domains (CBD) 1 and 
2 of human E-selectin ligated to the hinge, CH2 and CH3 regions 
of human IgG 1 (61). 
E-selectin, HuRa-2, was produced by substitution of rabbit 
residues with their human counterparts at positions 98 and 
101 (P98E and TI01V) in the HuRa-1 background. In contrast 
to the pattern observed with rabbit E-selectin and HuRa-1, 
COS cells transfected with HuRa-2 did bind mAb 3B7, and 
adhesion of HL60 cells to these cells was significantly in- 
hibited by mAb 3B7 (Fig. 3 B). 
To facilitate further mAb mapping and allow for direct 
carbohydrate binding studies (see below), mutations were in- 
troduced into the lectin domain of an E-selectin-human IgG 
chimera that is similar to a previously described L-selectin- 
IgG chimera (Fig. 2 B) (18, 61). The E-selectin-IgG chimera 
allowed for easy quantitation of individual mutants by analy- 
sis of  the amount of  human IgG produced from each transient 
cell transfection assay (see Materials and Methods). The in- 
clusion of the human IgG tail also allowed for rapid analysis 
of the ability of each mutant to bind the anti-E-selectin anti- 
body panel, as well as to immobilized sLe,, by use of la- 
beled anti-IgG antibody. In this way, amino acid substitutions 
which affected global lectin structure (loss of recognition by 
all mAbs), localized structure (loss of recognition by a sub- 
set of mAbs), and carbohydrate recognition (loss of sugar 
recognition with retention of recognition by  most or  all 
mAbs) could be rapidly differentiated (see Table I). 
Fig. 5 shows a number of amino acid substitutions that ap- 
pear to affect the binding of various mAbs to E-selectin. 
Since the chimeric construct of the lectin domains of human 
and rabbit E-selectin (HuRa-1) identified the NH2-terminal 
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antibodies  to  human-rabbit 
chimeras. (A) Immunottuores- 
cence localization of antibody 
binding  to human E-selectin 
lee-egf-CD16 (column 1), rab- 
bit  E-selectin  lec-egf CD16 
(column 2),  and HuRa-1, hu- 
man-rabbit chimeric E-selec- 
tin  lectin-egf  CD16 (column 
3) transfected  COS cells. Tram- 
fected  cells  were  fixed  and 
stained  with mAbs 3137 (row 
1), 7H5 (row 2), 8E4 (row 3), 
or 14(32 (row 4). (B) Binding 
and  inhibition  of HL60 cell 
adhesion  to HuRa-2 by mAb 
3B7. (a) Immunofluorescence 
localization  of antibody  3B7 
binding to HuRa-2 transfected 
COS cells;  (b) HL60 cell ad- 
hesion to HuRa-2 transfected 
COS cell monolayers; and (c) 
inhibition of HL60 cell adhe- 
sion to HuRa-2 by mAb 3B7. 
Cells were preincubated  with 
mAb 3B'/ (10 #g/ml)  for 1 h 
and  coincubated  with  HL60 
cells for 30 min at 25~ 
nine amino acids as forming at least part of the epitopes for 
three blocking antibodies (8E4, 7H5, and ENA-1), we first 
constructed further mutants within this region, concentrat- 
ing on the five positions (residues 2, 4, 5, 7, and 9) which 
differ between rabbit and human. A human E-selectin-IgG 
chimera in which residues 2, 4, and 5 were mutated retained 
binding to the entire panel of  antibodies, indicating that these 
amino acids are not critical for mAb binding (Table I). How- 
ever, a mutation which replaces the human E-selectin amino 
acids at positions 7 and 9 with their rabbit counterparts re- 
suited in loss of binding of antibodies 7H5, 8E4, and ENA-1 
(Fig. 5 A). The loss of binding of these three mAbs directly 
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Figure 4. HL60 binding to HuRa-1 in the presence of blocking anti- 
bodies.  Inhibition of HL60 binding to human E-selectin lec-egf- 
CD16 (m), rabbit  E-selectin  lec-egf-CD16 (t3), and  HuRa4  hu- 
man-rabbit chimeric  E-selectin  lectin-egf-CD16  ([]) transfected 
COS ceils by anti-E-selectin  blocking mAbs.  Cells were prein- 
cubated with 3B'/, 7H5, 8E4, or 14G2 (10 #g/ml) for I h and HL60 
cell adhesion determined  as described in Materials and Methods. 
Each bar represents the mean  •  SD of triplicate determinations. 
(A)  T7A,A9N 
corresponded to the gain of binding demonstrated with the 
HuRa-1  chimera.  Another  NH2-terminal  mutation,  E8A, 
was found to abolish the binding of BBA2 and ENA 1 (Fig. 
5  C).  Thus,  in agreement with the human-rabbit chimera 
studies described above, residues at positions 7, 8, and 9 of 
the E-selectin lectin domain contribute to the epitopes recog- 
nized by four blocking mAbs. 
Since the HuRa-2 chimera implicated residues 98 and 101 
in binding of blocking antibody 3B7,  the converse experi- 
ment was also done where the residues at these two sites in 
the E-selectin-IgG construct were replaced with their rabbit 
equivalents. The resultant mutant was found to not bind mAb 
3B7 (Fig.  5 B), thus confirming the gain of binding found 
with HuRa-2. Finally, an E-selectin-IgG mutant which con- 
tained an alanine substitution at position 101 retained bind- 
ing to mAb 3B7 (Table I), indicating that E98 was the crucial 
component of the 3B'/epitope. 
The  complexity of the  epitope  recognized by blocking 
rnAb 7H5 is revealed by the mutation K113A (Fig. 5 D). This 
substitution, which is at the COOH terminus of the lectin do- 
(B)  E98P, V101T 
~0 
.=. 
r., 
t.-, 
0 
to 
1 O0 
rnQ3W  ~ 
1 O0 
0 
1 O0 
(C)  E8A 
100 
(D)  KI13A 
m'~Z,:~l,~,.O'~,-,~ 
r,, 
0 
100 
(E)  K74A 
I O0 
(F)  $47D  Figure  5.  Reactivity  of anti- 
E-selectin mAbs with mutant 
chimeras. E-selectin-IgG chi- 
meras with the mutations shown 
were  tested  for  capture  by 
each  of  15  mAbs using  the 
ELISA  format  described  in 
Materials  and  Methods.  Re- 
sults shown represent the mean 
+  SD of duplicate determina- 
tions and are expressed as per- 
centage  of control  or  wild- 
type binding. 
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E  selectin-IgG mutant 
mAb binding 
BBAI  BBA2  ENA1  3B7  8FA  7H5  9H9  1B3  llG5  1E5  14G2  4D9  1D6  9A1  7El0  sLEX binding 
S2T N4H  T5Y  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
T7A A9N  +  +  -  +  -  -  +  +  +  +  +  +  +  +  +  ND 
E8A  +  -  -  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
M10Y TllS  Y12W  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
K32A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
$43A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
$45A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
P46A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
$47A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
$47D  +  +  +  +  +  -  +  +  +  +  +  +  +  +  +  - 
Y48F  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  - 
K67A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
K74A  +  +  +  +  +  +  -  -  -  +  +  -  -  +  +  + 
R84A K86A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
R97A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  - 
E98P  VI01T  +  +  +  -  +  +  +  +  +  +  +  +  +  +  +  ND 
K99A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
D100A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
VIOLA  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
EI07A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + 
KlllA  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  - 
Kll3A  +  +  +  +  +  -  +  +  +  +  +  +  +  +  +  - 
M10A  .............  +  - 
Y12A  .............  +  - 
EI4A  not expressed 
Y44A  not expressed 
Y48A  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  ND 
Y49A  ...............  ND 
E92A  +  +  +  +  +  -  +  +  +  +  +  +  +  +  +  ND 
I93A  ND  ND  ND  ..........  +  +  ND 
Y94A  ND  ND  ND  ............  ND 
I95A  ND  ND  ND  ............  ND 
K96A  .............  +  + 
E98A  ND  ND  ND  ..........  +  +  ND 
M103A  •  5:  •  4-  +  +  :i:  •  :t:  +  :i:  4-  :i:  +  +  - 
E14I,  A15S,  SI6R,  A17K  ND  ND  ND  ............  ND 
Y18A,  Q20A,  R22A  ................ 
N39A,  Y44A  ................ 
R54A,  K55A,  N57A  .............  +  + 
K96A,  R97A,  K99A  ................ 
KlllS,  K112A,  Kll3A  ................ 
+, Binding;  +, partial binding;  -,  no binding. 
main,  completely  abolished 7H5 binding.  Since 7H5 binding 
was also abolished  by substitutions  made  at the NH:  termi- 
nus of the lectin domain  (positions  7  and  9,  Fig.  5  A),  this 
suggested  that the epitope  recognized  by this blocking  anti- 
body  is derived  from  both  the NH2 and  COOH  termini.  In- 
deed,  the partial loss of 7H5 binding  found after substitution 
at residues  98 and  101  (Fig.  5  B)  was consistent  with close 
alignment  of this region  with the NH2- and COOH-terrninal 
sites recognized  by this mAb  as well.  One  interpretation  of 
this result is that these regions may be closely aligned in the 
tertiary  structure  of the  lectin  domain  (see below). 
The  binding  of  all  of  the  nonblocking  mAbs  was  not 
grossly  affected  by  substitutions  that  disrupted  blocking 
mAb  recognition  (Fig.  5,  A-D).  This  was  consistent  with 
these  two  antibody  classes  recognizing  distant  sites  in  the 
lectin domain.  For example,  mutant  K74A  completely  lost 
binding  of a  number  of these nonblocking  antibodies  (9H9, 
1B3,  llG5,  4D9,  and  1D6)  and partially  lost binding  of an- 
other (14G2) (Fig. 5 E).  This substitution did not affect bind- 
ing of any blocking  mAbs,  suggesting that this region  is not 
directly  involved  in carbohydrate  recognition. 
Lastly,  a  number  of amino  acid  substitutions  resulted  in 
the loss of binding  to all  of the antibodies  in the panel,  in- 
cluding 9A1  and 7El0,  which  recognize  determinants  in the 
complement-binding-like  domains  1  and  2  of  E-selectin. 
This result was obtained  even though  normalized  amounts  of 
these mutants,  based upon  human  IgG concentrations,  were 
added  to  the  antibody-coated  wells.  These  substitutions, 
therefore, appeared  to have global effects on the recombinant 
E-selectin domains,  and the apparent  lack of mAb  reactivity 
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and other data on the binding of mAbs to various E-selectin 
mutants are summarized in Table I. 
Carbohydrate Recognition by E-selectin Mutants 
While the mAb-mapping data described above were consis- 
tent with the involvement of the NH2 and COOH termini as 
well as the region surrounding residue 98 of the E-selectin 
lectin  domain  with  carbohydrate  recognition,  the  large 
"shadow" cast on an antigen by a bound antibody (typically 
680-880  A 2)  (15, 25)  may cause  blocking by  steric hin- 
drance of carbohydrate recognition sites relatively distant 
from the antibody epitope. Therefore, we analyzed the abil- 
ity of  a number of  the E-selectin-IgG alanine mutants to bind 
sLex glycolipid (27) that had been immobilized on plastic 
microtitre wells.  This assay has been validated previously 
(18),  where the binding of the E-selectin-IgG chimera was 
shown  to  be  calcium  dependent,  inhibited  by  E-selectin 
blocking mAbs  and dependent upon the  c~2-3 sialic acid 
form of sLe  ~. 
As can be seen in Fig. 6 A, three different results were ob- 
tained  with the various alanine substitutions  analyzed.  A 
number of substitutions did not affect the binding of E-selec- 
tin to immobilized sLe  x. These substitutions were found to 
be of the type that either did not affect the binding of any 
mAb (mutants K32A, K67A, and R84A, K86A) or affected 
binding  of only  nonblocking  antibodies  (mutant  K74A). 
This result was  consistent with  the previously mentioned 
possibility that this region of E-selectin was  not involved 
with  carbohydrate recognition.  Another effect was  exem- 
plified by mutations at positions R97, K99, and Kl13. Con- 
version of any of these sites to alanine either completely 
(R97 and K113) or almost completely (K99) abolished bind- 
ing of E-selectin to sLc  ~. While mutations at R97 and K99 
had no effect on blocking antibodies binding,  mutation at 
Kl13  completely abolished binding  of blocking  antibody 
7H5 (see above). In addition, residue E98 (adjacent to R97 
and K99)  was  crucial to the epitope of another blocking 
mAb,  3B7. These results unified the locations of blocking 
mAb epitopes with residues critical for carbohydrate recog- 
nition, and were consistent with the direct involvement of 
these regions of E-selectin with carbohydrate binding.  The 
final, somewhat unexpected, effect of E-selectin mutation on 
sLe  x binding was exemplified by the ESA mutant.  Fig. 6 A 
shows  that  this  mutant  appeared  to  show  enhanced  sLe  x 
binding when added at the same concentration as wild-type 
E-selectin chimera. A dose-response curve comparing ESA 
with wild-type E-selectin (Fig. 6 B) reveals that the mutant 
bound ~fivefold more avidly to sI.~ than wild type. This 
enhanced binding by ESA was completely calcium depen- 
dent and did not occur on the inactive a2-6 sialic acid form 
of the carbohydrate (data not shown).  As described previ- 
ously, substitutions in this region (i.e., at residues 7, 8, and 
9) profoundly affect the binding of several blocking mAbs. 
Thus, it is likely that this region of E-selectin is also as- 
sociated with ligand binding. Data on the ability of various 
E-selectin mutants to bind sLe  ￿9 are summarized in Table I. 
A Model of the E-selectin Lectin Domain 
While the results described above allow for a number of im- 
portant conclusions about the regions of the E-selectin linear 
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Figure 6. Binding of alanine mutants to immobilized sLe  ￿9 glyco- 
lipid. (A) E-selectin-IgG chimeras in which the indicated residues 
were mutated to alanine were tested for binding to immobilized 2,3 
sLe  x glycolipid by the ELISA procedure described in Materials 
and Methods. Results shown represent the mean 5: SD of triplicate 
determinations expressed as percentage of control or wild-type 
binding. (B) E-seleetin-IgG mutant ESA (o) or wild-type E-selec- 
tin-IgG (I) were tested at the indicated concentrations for binding 
to immobilized 2,3  sLe  x glycolipid by ELISA as above. Results 
shown represent the mean 5: SD of triplicate determinations. (C) 
E-selectin-IgG chimeras with the indicated mutations were tested 
for sLe  ￿9 binding as in A. 
sequence involved in carbohydrate recognition, their rele- 
vance would be enhanced if they could be applied to a struc- 
tural model of the lectin domain of this protein. In the ab- 
sence of crystallographic data, a three-dimensional model of 
a molecule can be constructed using structural coordinates 
of related molecules (22). Recently, the x-ray structure of the 
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of E-selectin, was determined (67). Therefore, to more fully 
understand the relative importance of  the functional residues 
described above, we used these structural data to develop a 
model of the E-selectin lectin domain. 
Derivation of the E-selectin model from the MBP coor- 
dinates was based on secondary structure common to both, 
encompassing 78 (of 121) E-selectin residues (67) (Fig. 7). 
Three models of E-selectin were evaluated, differing only in 
the conformation of two surface loops:  $43-Y48 and )(94- 
D100, corresponding to MBP K152-S154 and V199-D200, 
respectively. The $43-Y48 loop contains a three residue in- 
sertion relative to MBP while the Y94-D100  loop contains 
a five residue insertion. The E-selectin model before energy 
minimization had a root-mean-square (r.m.s.) deviation of 
0.17/~ (78 Ca atoms) while that of  the best energy-minimized 
model was 0.68/~. For comparative purposes, we also sub- 
jected  the  MBP  crystal  structure  to  the  same  energy- 
minimization regimen as used for E-selectin. The minimized 
MBP (molecule 1 only) showed a  Cc~ r.m.s,  deviation of 
0.45/~ (residues Kl10-C217, i.e., excluding seven NH2- and 
COOH-terminal  residues)  versus  the  crystal  structure. 
Hence the energy-minimization  regimen maintained the sec- 
ondary structure of the E-selectin model; this was accom- 
plished by initially constraining the secondary structure Ca 
atoms and hydrogen bonds during minimization. 
Weis et al. (67) noted the presence of small and large hy- 
drophobic cores in MBP that were critical for overall struc- 
ture. For the small core only two of six residues are con- 
served in E-selectin (G52,  Al15) though the model could 
accommodate the other four E-selectin sidechains without 
disturbing the protein fold. In the large core only 6 of 14 
residues are  conserved.  One substitution, A155(MBP)  to 
Y49(E-selectin), necessitated moving tx-helix-2 (K32-L42) 
slightly away from the protein center to accommodate in- 
troduction of the Y49 sidechain. This tyrosyl side chain in- 
teracts with the two loops $43-Y48 and Y94-D100 mentioned 
above. At the opposite (NH2 terminus) end of the helix, the 
substitution  of  P138(MBP)  to  I29(E-selectin)  also  con- 
tributed to the slight shift in t~-helix-2. However, the substi- 
tutions in E-selectin in the large hydrophobic core fill the in- 
ternal space created by the slight shift of a-helix-2. Thus, 
the relatively large number of amino acid changes in the hy- 
drophobic core regions of MBP and the E-selectin lectin do- 
main could be accommodated by the model. 
The MBP crystal structure contains two putative Ca  2§ 
binding sites which, in the crystal structure, are occupied by 
two Holmium ions. As noted by Weis et al. (67), site 2 is 
retained in E-selectin: E80 Oe2, N82 Odtl, E88 O~2, N105 
Ot51, D106 O~2, D106 backbone carbonyl oxygen, and one 
water  molecule  coordinate  this  Ca  2§  The  other  Ca  2§ 
binding site is probably not present in the E-selectin lectin 
domain,  also noted previously (67)  (Fig.  7).  While D89 
(D194 in MBP) is conserved in E-selectin, D161 in MBP is 
replaced  by K55  in  E-selectin  and two other  sidechains 
which  coordinate  the  MBP  site  1  Ca  2§  i.e.,  E165  and 
D188, are replaced by N57 and N83 in E-selectin. While an 
Asn  sidechain could  still  coordinate  a  Ca  2+  via  its  O~1 
atom, N57 is adjacent to a two residue deletion and the loop 
of which it is a part probably changes conformation. Like- 
wise, N83 is part of a loop which has a proposed conforma- 
tion in E-selectin different from that in MBP.  Though this 
loop contains no insertions or deletions, the MBP sequence 
HGSG forms a Type Ir reverse turn with the Gly at position 
4 having a backbone conformation allowable only for Gly 
(136 ~ 148~  The E-selectin sequence RQKD necessitated a 
different loop conformation due to the G to Q and G to D 
replacements. Thus, only one calcium binding site is pre- 
dicted in the E-selectin lectin domain. 
Of course, the most interesting aspect of this model is the 
location of the amino acid side chains whose mutation ap- 
peared to affect antibody binding and/or sLe~ recognition. 
As can be seen from the model (Fig.  7),  the amino acid 
residues involved in blocking mAb recognition appear to 
form a patch on the surface of the lectin domain near the an- 
tiparallel beta sheet formed by the disulfide-linked NH~ and 
COOH  termini  and  the  adjacent disulfide-linked  loop 
formed by the two internal cysteines. Thus, amino acid side 
chains at positions 7, 8, 9, 98, and 113, all of which affected 
the binding of various blocking mAbs, are all found to be on 
the same face of  E-selectin. Of  particular importance was the 
relatively close proximity of the side chains of residues 7, 9, 
and 113 which was consistent with the effect of mutations at 
these residues on the binding of the 7H5 blocking mAb. The 
partial effect of  mutation at residue 98 on 7H5 binding is also 
consistent with the model, since the loop containing this res- 
idue is found on the same face as residues 7, 9, and 113. The 
model also reveals that the side chain recognized by the non- 
blocking antibodies (K74) is found on a side of the lectin do- 
main that is opposite to that which appears to bind the block- 
ing antibodies (Fig. 7 A). This result is consistent with the 
region recognized by nonblocking antibodies being a consid- 
erable distance from the carbohydrate recognition site. 
Examination of the location of amino acids found to affect 
sLe" binding is consistent with the interpretation that the 
discrete structural region recognized by the blocking anti- 
bodies is in fact involved with carbohydrate recognition. All 
of the residues whose substitution affected sLe  ~ binding- 
ES, R97, K99, and Kll3-are found within this same region. 
Furthermore,  the  model  suggests  that  a  number  of side 
chains whose mutation did not affect sLe  ~ binding may be 
located on a side of the molecule that is distinct from the ap- 
parent sLe  ~ binding site. 
Mutations Based on Model Predictions 
To test and refine the E-seleetin model described above, we 
next introduced substitutions at additional residues predicted 
to comprise the face of E-selectin implicated in sugar bind- 
ing. For example, the model predicts that the small loop from 
$43  to Y48  (in purple,  Fig.  7  B)  lies within the region 
defined by the  blocking  mAb  and  sLe  ~ binding  studies. 
Consequently, mutagenesis of this loop (along with other 
residues in this region) was performed with the results shown 
in Fig. 6 C and summarized in Table I. Particularly notewor- 
thy is the observation that mutation of KIll to alanine com- 
pletely abolished sLe  ~ recognition (Fig. 6 C). Furthermore, 
mutation of residues within the $43-Y48 loop revealed that 
substitution at residues P46,  $47  or Y48 decreased sugar 
binding.  Whereas the  substitution $47A  significantly de- 
creased sLe  ￿9 binding by E-selectin-IgG, the $47D mutation 
resulted in a complete loss of carbohydrate binding. Also, al- 
though the $47D mutant still bound mAb 3B7, this mutant 
bound blocking mAb 8E4 weakly and did not bind blocking 
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the close alignment of this $43-Y48 loop with the aforemen- 
tioned binding sites for 8E4 and 7H5, as was predicted by 
the model. Finally, since the substitution Y48A resulted in 
a misfolded protein (see Table I), Tyr 48 was replaced with 
phenylalanine to evaluate the contribution of this  tyrosyl 
hydroxyl group to sLe  ~ recognition.  This substitution did 
not affect recognition by any of the antibodies (Table I) but 
completely  abolished  carbohydrate  binding  (Fig.  6  C). 
Thus, further mutagenesis based on the model revealed addi- 
tional components of the putative sLe  x binding site, all of 
which were entirely consistent with the predicted structure 
of the E-selectin lectin domain. 
Discussion 
The data reported here provide the first glimpse into the mo- 
lecular interactions between E-selectin and its carbohydrate 
ligand,  sLe  x.  The work reported here is unique in that it 
combines the mapping of blocking and nonblocking mAb 
binding sites with the ability of a given E-selectin mutant to 
bind  to  a  naturally  occurring carbohydrate ligand,  sLe  x. 
The agreement between blocking mAb mapping data and the 
location of mutations that affect sLe  x binding is consistent 
with the hypothesis that the small region of the E-selectin 
lectin domain identified here is directly involved with bind- 
ing to the previously defined face of sLe  x (1, 58). This pro- 
posal is also supported by the fact that many nonblocking 
mAbs appear to map to the opposite side of the lectin do- 
main. We therefore believe that we have identified an impor- 
tant carbohydrate recognition site on E-selectin. 
One of the most interesting aspects of the mutagenesis de- 
scribed here is the discovery that three positively charged 
residues  (R97,  Kill,  and Kl13)  that are critical for sLe  x 
recognition appear  very close together on  the  E-selectin 
model (Fig. 7). A major supposition of the mutagenic analy- 
sis was based upon the potential importance of positively 
charged residues. The discovery that substitution of alanine 
for either of  these side chains had profoundly negative effects 
on carbohydrate recognition supports the possibility that ba- 
sic residues in selectin lectin domains are involved in carbo- 
hydrate recognition (34,  55,  69).  One possible means by 
which this recognition could be accomplished is by charge 
interaction between these side chains and the carboxylate 
group of the sialic acid residue found in sLe  x. The impor- 
tance of this carboxylate group is underlined by organic syn- 
thesis  studies  demonstrating  that  an  sLex-like compound 
with a methyl ester on the sialic acid carboxylate is not effec- 
tively recognized by  E-selectin (56,  58).  Thus,  it  seems 
likely that some type of charge-mediated interaction may be 
involved with sLe, adhesion to E-selectin.  Since all three 
selectins require sialic acid for adhesion (10, 42, 46, 57, 58), 
it is interesting that, while Klll and Kl13 are found in all 
three selectins from a number of different species, a posi- 
tively charged residue (R) is found at position 97 of L and 
E-selectin, while human P-selectin contains a serine at this 
site. The conservation of lysines at positions 111 and 113 of 
all selectins (33), together with the mutagenesis analysis de- 
scribed  here,  is  consistent  with  a  direct  role  for  these 
residues in sialic acid recognition, perhaps by the formation 
of a salt bridge or hydrogen bond. The less stringent conser- 
vation between selectins at position 97 argues that this resi- 
due, while clearly involved with carbohydrate recognition, 
may have a less crucial role in sugar binding than residues 
K111 and Kll 3. It is also interesting to note that $47 and Y48, 
which were implicated in sugar binding by the mutagenesis 
here, are conserved in all three selectins. The data reported 
here also implicate the NH2 terminus of E-selectin in ligand 
binding.  Mutagenesis of the NH2 terminus was initially in- 
spired  by previous data  that mapped  the  epitope for the 
blocking mAb Mel  14 to the NH~ terminus of L-selectin 
(6).  In  agreement  with  that  study,  a  number of anti-E- 
selectin blocking mAbs were found to recognize residues in 
the NH2 terminus of this glycoprotein as well. In fact, of 
the  five blocking antibodies  that we  have analyzed,  four 
~BA 2, ENA 1, 8E4, and 7H5) have been directly shown 
to bind to this region of  E-selectin, consistent with a possible 
role for this site in binding and adhesion. The E8A mutation 
found to enhance carbohydrate binding  is  also  consistent 
with the involvement of this site in sugar recognition, al- 
though the nature of this interaction is unclear (see below). 
However, the enhanced recognition of sLe  x by mutation at 
position 8 may be of biological significance. As was pointed 
out  earlier,  selectins  appear  to  mediate  a  relatively low 
affinity "rolling" type of adhesion as a precursor to firmer 
adhesion mediated by leukocyte integrins (9, 36, 38, 59). It 
is possible that the NH2-terminal region of E-selectin has 
evolved to decrease the relative affinity of carbohydrate rec- 
ognition by incorporation of a relatively large side chain at 
this site. Accordingly, the other two selectins (L and P) con- 
tain a  lysine at residue  8,  and mutation of this lysine in 
L-selectin to an alanine  similarly  enhances sLe  ~ recogni- 
tion by 5-10-fold (D. Erbe, unpublished data). It thus seems 
possible that a large, charged side chain at this site may serve 
to decrease the affinity of selectin-carbohydrate interactions. 
Figure 7. A model of the lectin domain of E-selectin. Shown is a ribbon model of the E-selectin lectin domain derived from the published 
coordinates of the related type-C lectin, the mannose binding protein (67). Orientation A shows the amino acid residues whose mutation 
did not affect sLe  x or mAb binding (brown), the residue at position 74 whose mutation did not affect sLe  x binding but did affect binding 
of nonblocking mAbs (pink), the residues at positions 7,9, and 98 whose mutation abolished binding of blocking mAbs (red), the residues 
at positions 97, 99,  113 whose mutation abolished sLe  x binding (yellow), and the residue at position 8 whose mutation enhanced the 
affinity of E-selectin for sLe  x (green). As noted in the text, mutation of residues 8 and 113 also affected the binding of some blocking 
mAbs. The single bound calcium is depicted as a blue ball. Orientation B shows the "active site" of carbohydrate binding from a face-on 
view, with residues involved with carbohydrate recognition and/or blocking mAb binding colored as in orientation A. The purple loop 
(residues $43-Y48) and the dark blue loop (residues Y94-D100) denote two loops near the carbohydrate binding site of E-selectin that 
are not found in the MBP. Orientation C shows the E-selectin model as in A (but rotated slightly towards the viewer) with all of the residues 
whose mutation significantly decreased sLe  x binding shown in yellow (from top to bottom: K99, P46, R97, $47, Y48, Kl13, Klll). For 
the purpose of relative size comparison, the solution structure of sLe  x is also shown with the known crucial carbohydrate moieties, the 
carboxylate of sialic acid, the 4 and 6 hydroxyls of galactose, and the 2, 3, and 4 hydroxyls of fucose (58), colored red. Bars, 10~. 
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(and those surrounding  it) does not appear to be important 
(see Fig. 2) (33), it is unlikely that this residue is directly 
involved in sLe  ~ binding.  Rather, this site may affect acces- 
sibility and/or flexibility of the sugar  binding site. 
While the other E-selectin residues delineated here may be 
directly involved with sLe  ~ recognition (see Fig. 7  C), in- 
direct effects may also play a role in the loss of binding by 
some mutants.  For example,  The K99A  substitution  may 
have affected sLe  ~ binding indirectly by changing the Y94- 
D100 loop conformation such that R97 no longer formed a 
stable  contact  with  the  carbohydrate.  In  fact,  when  this 
K99A mutant IgG chimera was tested in an HL60 cell bind- 
ing  assay,  it  mediated  adhesion  comparable  to  wild-type 
E-selectin-IgG, while the R97A, K111A, and K113A mutants 
were  completely  negative  for  HL60  cell  binding  03. 
Wolitzky, unpublished data).  This result is consistent with 
the possibility that the K99A substitution affects  sLe  ~ bind- 
ing indirectly.  A  similar situation may occur in which the 
P46A  substitution  affects the  $43-Y48  loop such that $47 
and/or Y48  no longer contact the  sugar.  Another indirect 
effect of these mutations might involve interactions between 
the  EGF  and  lectin  domains.  Previous  data  have  clearly 
demonstrated a role for the EGF domain in mediation of lec- 
tin domain structure  in selectins (6, 60).  However, it must 
be emphasized that the retention of mAb binding to the mu- 
tants described here is not consistent with the structural dis- 
ruptions expected after loss of interaction between the lectin 
and EGF domains (6, 60).  Lastly,  mutagenesis of the man- 
nose binding protein indicated that  some substitutions  re- 
sulted in a decreased affinity  for calcium and a subsequent 
loss of sugar binding.  Higher calcium levels restored man- 
nose binding by these mutants (47a). However, the E-selectin 
mutants described here still did not bind sLe  x at calcium 
concentrations as high as 20 mM 03. Brandley,  unpublished 
data). Therefore, our results are most consistent with a direct 
role for at least R97, Klll, and Kl13, and perhaps $47 and 
Y48,  in sLe  x binding by E-selectin (see Fig.  7  C). 
Recently, Geng and co-workers showed that a mAb capa- 
ble of inhibiting neutrophil binding to P-selectin mapped to 
residues  19-34 of this molecule, and that a peptide corre- 
sponding to this stretch also inhibited neutrophil binding to 
P-selectin (21).  In the model of E-selectin presented here, 
residues  19-34  form a loop which is on the opposite side 
from the site where sLe  x appears  to bind. The two mutants 
made within this sequence in E-selectin either did not affect 
sLe  x or mAb binding (mutant  K32A)  or resulted in a mis- 
folded protein (Mutant Y18A, Q20A, R22A). Thus our data 
are not consistent with the direct involvement of this region 
in carbohydrate  recognition by E-selectin,  although an ex- 
tensive mutational analysis of this loop was not performed. 
Recognition of cell surface carbohydrates  by selectins is 
one of the most important events during normal and patho- 
genic inflammatory responses. The data reported in this pa- 
per provide a preliminary view of some of the molecular in- 
teractions  that  mediate  this  type  of adhesion.  While  the 
ultimate depiction of the association between a ligand and 
receptor requires crystallization of the complexes formed 
between them, mutagenic investigations similar to that re- 
ported here have been found to give a highly informative 
representation of the true nature of ligand-receptor interac- 
tions (12,  13,  14,  16, 68). Furthermore, the work described 
here should complement crystallographic analysis by indi- 
eating which residues at the protein-carbohydrate interface 
contribute most to binding energy. Perhaps the greatest use 
of the E-selectin model described herein will be to focus fur- 
ther  structure/function  studies  aimed  at  the  design  of 
carbohydrate-based inhibitors of E-selectin/sLe  x binding. It 
is hoped that such drugs may ultimately find use as effective 
inhibitors of inflammatory responses mediated by selectins. 
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